Archive: October 2024


Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models

Naltrexone reduces craving for alcohol and has been found to be most effective in reducing heavy drinking (25). The efficacy of naltrexone in reducing relapse to heavy drinking, in comparison …

Read more
Loading